About Med-Cannabis2019
Med-Cannabis2019 follows the success of the first Congress held in Vienna and will continue to address the many controversies surrounding cannabis-based medicines. Strong public and patient demand has led to the decision to allow cannabis products for medical use in most European countries. There is a lot of basic-science and clinical research on the potential use of cannabis products for chronic pain and cancer management as well as controversies on the potential harms.
Speakers
Agenda
Thursday, 23 May 2019
08:00-17:00 Registration
08:50-09:00 Welcome and Opening of the CongressCongress Chairs: Silviu Brill, IsraelWInfried Hauser, GermanyEuropean Pain Federation EFIC President: Bart Morlion, Belgium
09:00-10:30 Session1:Basic Science: What's New?
09:00-09:30 Translational Research Program Surrounding Cannabis and CannabinoidsCaroline Baglole, McGill University, Canada
09:30-10:00 Apprasing the EntourageDavid Meiri, Technion, Israel Institute of Technology, Israel
10:00-10:30 The Endocannabinoid System as a Novel Therapeutic Target for Pain and CNS Disorders: Can the Promise be Realised?David Finn, National University of Ireland, Ireland
10:30-11:00 Networking, Coffee Break and Visit the Exhibition and Posters
11:00-12:30 Session 2:Children and Adolescents
11:00-11:30 Pediatric Palliative CareSven Gottschling, University Clinic Saarland, Germany
11:30-12:00 EpilepsyUri Kramer, Tel Aviv University, Israel
12:00-12:30 Psychosocial Consequences of Regular Recreational Cannabis UseEva Hoch, Ludwig Maximilian University, Germany
12:30-13:30 Networking, Lunch Break and Visit the Exhibition and Posters
13:30-15:00 Session3:Position Papers of Scientific Societies
13:30-13:50 Position of the European Pain Federation EFIC® on Appropriate Use of Cannabis‐Based Medicines and Medical Cannabis for Chronic Pain ManagementBart Morlion, European Pain Federation EFIC, Belgium
13:50-14:10 Canadian Association of RheumatologyMary-Ann Fitzcharles, McGill University, Canada
14:10-14:30 Role of Recommendations within a Unique Legal Context in Germany Frank Petzke, University Clinic Gottingen, Germany
14:30-15:00 Discussion
15:00-15:30 Networking, Coffee Break and Visit the Exhibition and Posters
15:30-17:00 Session 4:Promises at the Borders of Pain Medicine
15:30-15:50Refractory EpilepsySilvia Kochen, National University of Buenos Aires, Argentina
15:50-16:10 CancerIdo Wolf, Tel Aviv Medical Center, Israel
16:10-16:30 Inflammatory Bowel DiseasesJost Langhorst, University Bamberg, Germany
16:30-17:00 Discussion
17:00 End of Day 1
Friday, 24May 2019
08:00-16:30 Registration
08:30-10:30 Session 5:Controversies on Cannabis-Based Medicines
08:30-09:30 Do We Need Cannabis Clinics and Doctors? Itay Goor Aryeh, Sheba Medical Center, Israel Pro Perspective Caroline MacCallum, University of British Columbia, CanadaTina Horsted, Clinic Horsted, Denmark Con PerspectiveMary-Ann Fitzcharles, Pain Center, McGill University, Canada
09:30-10:00 Panel Discussion: Do Physicians Need a Special Qualification?Mary-Ann Fitzcharles, Pain Center, McGill University, CanadaWinfried Häuser, Technical University Munchen, GermanyHaggai Sharon, St. Thomas NHS Foundation Trust, UKPiercarlo Sarzi-Puttini, ASST Fatebenefratelli-Sacco, University of Milan, Italy
10:00-10:30 Panel Discussion: To Drive or not to Drive? Moderator: Silviu Brill, IsraelCaroline MacCallum, University of British Columbia, CanadaDavid Finn, National University of Ireland, IrelandItay Goor Aryeh, Sheba Medical Center, IsraelPiercarlo Sarzi-Puttini, ASST Fatebenefratelli-Sacco, University of Milan, Italy
10:30-11:00 Networking, Coffee Break and Visit the Exhibition and Posters
11:00-12:30 Session 6:National Experiences
11:00-11:10 Czech Republic ExperienceTomas Zabransky, International Cannabis and Cannabinoids Institute and Charles University, Czech Republic
11:10-11:20 German ExperienceFrank Petzke, University Clinic Gottingen, Germany
11:20-11:30 Irish ExperienceDavid Finn, National University of Ireland, Ireland
11:30-11:40 South American ExperienceSilvia Kochen, National University of Buenos Aires, Argentina
11:40-11:50 United Kingdom ExperienceAnne Katrin Schlag, King's College London, United Kingdom
11:50-12:30 Panel Discussion
12:30-13:30 Networking, Lunch Break and Visit the Exhibition and Posters
13:30-14:30 Session 7:Who Should Educate the Patient?
13:30-13:45 State of Medical Cannabis Education in the EU and the WorldGregor Zorn, European Cannabinoid Therapy Association - ECTA, Slovenia
13:45-14:00 The Role of NursesMiri Ogintz, The Rambam Hospital, Israel
14:00-14:15 The Role of Pharmacists Mark Feldschuh, Australian Institute of Pharmacy Management, Australia
14:15-14:30 Discussion
14:30-15:00 Networking, Coffee Break and Visit the Exhibition and Posters
15:00-16:30 Session 8:Evidence-Based Cannabis Medicines: What's New?15:00-15:15Long-Term Treatment with Cannabis in FibromyalgiaPiercarlo Sarzi-Puttini, ASST Fatebenefratelli-Sacco, University of Milan, Italy
15:15-15:30 German Patient Register of Sativex for Chronic PainMichael Überall, DGS-Center of Excellence for Health Care Research, Germany
15:30-15:45 Israeli Registry DataTBD
15:45-16:00 Systematic Review and Meta-Analysis of Cannabis-Based Medicines for Cancer PainWinfried Häuser, Technical University Munchen,
16:00-16:30Congress Closing Remarks
